SHPH Shuttle Pharmaceuticals Holdings, Inc.
Company Analysis
Latest News
Shuttle Pharmaceuticals Dismisses Independent Auditor Forvis Mazars, LLP
Shuttle Pharmaceuticals Holdings, Inc. announced the dismissal of Forvis Mazars, LLP as its independent registered public accounting firm. The decision was...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 22, 2026
Shuttle Pharmaceuticals is expected to report zero revenue and a net loss for the second quarter of 2026, with shares currently trading at $3.21, slightly...
Shuttle Pharmaceuticals Issues Common Stock, Warrants, and Pre-Funded Warrants
Shuttle Pharmaceuticals Holdings, Inc. announced the issuance of various unregistered equity securities following stockholder approval obtained at a Special...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 15, 2026
Shuttle Pharmaceuticals is expected to report zero revenue and a projected EPS loss of -$0.43 for the second quarter, while its $3.53 stock price currently...
Shuttle Pharmaceuticals Shareholders Approve Name Change to United Compute Inc. and Merger-Related Share Issuances
Shuttle Pharmaceuticals (SHPH) announced that its stockholders have approved all proposals at a Special Meeting held on September 9, 2026. Key approvals...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 08, 2026
Consensus revenue for the second quarter is estimated at $0.0 million as Shuttle Pharmaceuticals remains a pre-revenue entity, while formal analyst EPS...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 01, 2026
Consensus revenue is expected to be $0.00 with a projected loss per share of -$0.43, while the current stock price of $3.54 sits slightly below the modest...
Receives Nasdaq Non-Compliance Notice for Delayed Quarterly Report Filing
Shuttle Pharmaceuticals received a notification from Nasdaq on August 28, 2026, indicating non-compliance with listing requirements due to the delayed filing...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 25, 2026
Shuttle Pharmaceuticals is expected to report a Q2 2026 loss of approximately $0.45 per share on $0.00 in revenue, with the current stock price of $3.76...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 18, 2026
Shuttle Pharmaceuticals is expected to report second-quarter 2026 revenue of $0.00 and a consensus EPS of $0.00, with the stock trading at $4.07 against an...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Shuttle Pharmaceuticals is expected to report zero revenue and a consensus EPS loss of $4.30 for Q2 2026, with the stock trading at $4.36 relative to a...
🔴 Shuttle Pharmaceuticals is trading 8.2% down today on insider selling and United Dogecoin merger dilution concerns
Shuttle Pharmaceuticals is trading 8.2% down at $3.01 after a string of insider sales and growing dilution concerns tied to its United Dogecoin merger. -...
🔴 Shuttle Pharmaceuticals is trading 5.2% down today on insider selling and post-merger dilution concerns
Shuttle Pharmaceuticals is trading at $3.11 (-5.18%) in pre-market, continuing its downward trajectory following Thursday’s sharp selloff. • The decline is...
🔴 Shuttle Pharmaceuticals is trading 10.6% down
Shuttle Pharmaceuticals is trading at $3.19, down 10.6% from a comparison close of $3.57 during regular trading. This is a price-action follow-up, so a...
🔴 Shuttle Pharmaceuticals is trading 8.7% down today following post-rally volatility
Shuttle Pharmaceuticals is trading 8.7% down at $3.26 today as the stock experiences post-rally volatility following a significant gain in the previous...
🔴 Shuttle Pharmaceuticals is trading 10.9% down
Shuttle Pharmaceuticals is trading at $3.18, down 10.9% from a comparison close of $3.57 during pre-market. This is a price-action follow-up, so a separate...
🔴 Shuttle Pharmaceuticals is trading 9.1% down today as it pulls back from a previous 9.5% gain with no fresh catalysts
Shuttle Pharmaceuticals is trading at $3.24 (-9.11%) in pre-market, pulling back after a significant gain in the previous session. • The move follows a 9.51%...
🔴 SHPH is trading 5.6% down today after a sharp regular-session gain
SHPH is trading at $3.37 (5.6% down) in after-hours, pulling back from a sharp 9.5% regular-session gain to $3.57. • No fresh company-specific news, earnings,...
🟢 SHPH extends move to 6.4% up
SHPH is trading at $3.47, up 6.4% versus the comparison close of $3.26 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SHPH is trading 5.2% up today as it pivots from drug development to Dogecoin mining
SHPH is trading 5.2% up at $3.43 following the company’s formal pivot from drug development to cryptocurrency mining. • The strategic shift follows the...